Pharmafile Logo
Pharmafocus logo
Advanced Search

US

Showing 15 posts of 324 posts found.

architect_of_the_capitol_2

US “right to try” legislation passes after initial defeat

March 22, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten

Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …

News
architect_of_the_capitol

US “right to try” experimental drug bill defeated in House vote

March 14, 2018
Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Opioids are no more effective than common painkillers, study reveals

March 8, 2018
Medical Communications, Research and Development US, opioid crisis, opioids, pharma

A team of researchers at the Minneapolis Veterans Affairs Health Care System has found that, for all their risks, opioids …

News
dengvaxia

Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018
Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …

News
gilead-sciences

FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit

February 8, 2018
Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma

Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.

News
brenda_fitzgerald_official_photo

CDC Director resigns over tobacco stock scandal

January 31, 2018
Medical Communications Brenda Fitzgerald, CDC, US, pharma

Dr Brenda Fitzgerald, the Director of the Centers for Disease Control and Prevention, the United States’ leading national public health …

News
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

News
novartis_outside_1

Novartis’ CAR T therapy Kymriah scores accelerated approval in both Europe and US

January 17, 2018
Research and Development, Sales and Marketing CAR T, CAR-T, EMA, Europe, FDA, Kymriah, Novartis, US, pharma

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …

News
homeopathy-1063292_640

FDA pledges to crack down on homeopathy treatments

December 19, 2017
Manufacturing and Production, Sales and Marketing FDA homeopathy, US, pharma

Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to …

News
opioid_crisis

FDA approves first and only therapy of its kind for opioid addiction

December 1, 2017
Medical Communications, Sales and Marketing FDA, Invidior, Sublocade, US, opioid crisis, opioids, pharma

Image Credit:  Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …

News
shutterstock_254160583

US federal government withdraws approval of major patient charity over donor misconduct

November 30, 2017
Medical Communications, Sales and Marketing Caring Voice Coalition, US, US government, patient charity, pharma

The Department of Health and Human Services’ Office of Inspector General (OIG) has rescinded authorisation for one of the US’ …

News
pixabay_puzzle-268905_640

European biotechs outperform US for investment return, report claims

November 29, 2017
Medical Communications, Sales and Marketing EU, Europe, US, investment, pharma

A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …

News
shutterstock_95714119

Children are still prescribed codeine despite FDA warnings, study finds

November 20, 2017
Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

News

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017
Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025